SCHEMBL9528463

SCHEMBL9528463

O=c1[nH]nccc1NCCN1CCN(c2ccccc2O)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ DRD4 P21917 1/20 0.45
▸ ADRA1B P35368 3/20 0.45
▸ HTR1A P08908 8/20 0.44
▸ ADRA1D P25100 2/20 0.44
▸ GFER P55789 1/20 0.43
▸ HTR7 P34969 8/20 0.43
▸ HTR2C P28335 5/20 0.43
▸ HTR1D P28221 4/20 0.43
▸ HTR2B P41595 4/20 0.43
▸ HTR5A P47898 4/20 0.43
▸ HTR6 P50406 4/20 0.43
▸ HTR2A P28223 2/20 0.43
▸ ADRA1A P35348 2/20 0.43
▸ DRD2 P14416 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27263078 0.86 HTR1A (0.41) GAAALDH1A1DRD4ADRA1BHTR1A
SCHEMBL9527044 0.84 HTR1A (0.63) DRD4ADRA1BHTR1AADRA1DADRA1A
SCHEMBL6586501 0.83 HTR7 (0.48) HTR1AHTR7HTR6HTR2ADRD2
SCHEMBL9527118 0.81 HTR1A (0.52) GAAADRA1BHTR1AADRA1DGFER
SCHEMBL10431149 0.78 HTR7 (0.43) GAAADRA1BHTR1AADRA1DHTR7
SCHEMBL9528402 0.78 HTR1A (0.61) ADRA1BHTR1AADRA1DHTR7HTR2B
SCHEMBL9527740 0.77 DRD2 (0.64) DRD4ADRA1BHTR1AADRA1DHTR7
SCHEMBL9527347 0.76 HTR1A (0.52) ADRA1BHTR1AADRA1DHTR7HTR6
SCHEMBL4616926 0.75 ADRA1A (0.62) GAAHTR1AGFERADRA1ADRD2
SCHEMBL11447503 0.74 HTR1A (0.51) GAAALDH1A1DRD4HTR1AGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0372305-B1 PIPERAZINYLALKYL-3(2H)-PYRIDAZINONES, METHOD FOR THEIR PREPARATION AND THEIR USE AS ANTIHYPERTENSIVE AGENTS Hafslund Nycomed Pharma Aktiengesellschaft (AT) 1993-08-04 — — EP disclosed
US-5034391-A Piperazinylalkyl-3(2H)-pyridazinones and the use thereof as agents lowering blood pressure CL PHARMA AKTIENGESELLSCHAFT (AT) 1991-07-23 — — US disclosed
EP-0372305-A1 Piperazinylalkyl-3(2H)-pyridazinones, method for their preparation and their use as antihypertensive agents Hafslund Nycomed Pharma Aktiengesellschaft (AT) 1990-06-13 — — EP disclosed
Send feedback